Type 2 Diabetes
Showing NaN - NaN of 71
Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Obesity Trial in United States (HU6, Placebo)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
- HU6
- Placebo
-
Montclair, California
- +5 more
Jul 31, 2023
Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- LY3209590
- Insulin Degludec
-
Little Rock, Arkansas
- +129 more
Jan 19, 2023
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),
Completed
- Type 2 Diabetes
- Comparative Effectiveness of Glycemia-lowering Medications
- Sulfonylurea (glimepiride)
- +3 more
-
Birmingham, Alabama
- +35 more
Apr 13, 2022
Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, LantusĀ®)
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Dapagliflozin )
Completed
- Type 2 Diabetes
- Dapagliflozin
- Dapagliflozin placebo
-
New Haven, Connecticut
- +41 more
Jan 28, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)
Completed
- Type 2 Diabetes
-
Birmingham, Alabama
- +126 more
Jan 21, 2022
Type 2 Diabetes Trial in Australia, China, United States (INS068 injection, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- INS068 injection
- Insulin Degludec
-
Huntington Park, California
- +32 more
Jan 27, 2022
Type 2 Diabetes Trial in United States (BT-001, Physician-guided Standard of Care for type 2 diabetes)
Active, not recruiting
- Type 2 Diabetes
- BT-001
- Physician-guided Standard of Care for type 2 diabetes
-
San Francisco, California
- +5 more
Jan 13, 2022
Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)
Completed
- Type 2 Diabetes
- Liraglutide + OADs
- Glargine + OADs
-
Miami, Florida
- +4 more
Oct 5, 2021
Coronavirus Infection, Type 2 Diabetes Trial in Miami (Linagliptin, Insulin regimen)
Withdrawn
- Coronavirus Infection
- Type 2 Diabetes
- Linagliptin
- Insulin regimen
-
Miami, FloridaUniversity of Miami
Jun 7, 2021
Type 2 Diabetes Trial in Miami (Dapagliflozin, Metformin, Placebo)
Type 2 Diabetes Trial in United States (Mesenchymal Precursor Cells (MPCs))
Completed
- Type 2 Diabetes
- Mesenchymal Precursor Cells (MPCs)
-
Garden Grove, California
- +17 more
Jun 1, 2020
Type 2 Diabetes, Chronic Kidney Disease Trial in Worldwide (Dulaglutide, Insulin glargine, Insulin lispro)
Completed
- Type 2 Diabetes
- Chronic Kidney Disease
- Dulaglutide
- +2 more
-
Montgomery, Alabama
- +88 more
Sep 6, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Type 2 Diabetes, Overweight, Obesity Trial in Miami (Liraglutide, Metformin)
Completed
- Type 2 Diabetes
- +2 more
-
Miami, FloridaUniversity of Miami
Jun 4, 2019
Type 2 Diabetes Trial in United States (MEDI-4166, Placebo)
Completed
- Type 2 Diabetes
- MEDI-4166
- Placebo
-
Anniston, Alabama
- +10 more
Mar 12, 2019
Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))
Terminated
- Type 2 Diabetes
- ITCA 650 (exenatide in DUROS)
-
Birmingham, Alabama
- +50 more
Mar 4, 2019